메뉴 건너뛰기




Volumn 35, Issue 1, 2010, Pages 9-16

Anaplastic thyroid carcinoma: Practical aspects of multimodal therapy and data emerging from a 40-year experience at a single Italian institution

Author keywords

Combined modality therapy; Radiotherapy; Thyroid neoplasms

Indexed keywords

BLEOMYCIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; HISTONE DEACETYLASE INHIBITOR; IODINE 131; MITOXANTRONE; PROTEIN P53; PROTEIN TYROSINE KINASE INHIBITOR; VINCRISTINE;

EID: 77953559127     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (8)

References (29)
  • 1
    • 0031028402 scopus 로고    scopus 로고
    • Prognostic factors for thyroid carcinoma: A population-based study of 15 698 cases from the surveillance, epidemiology and end results (SEER) program 1973-1991
    • Gilland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma: a population-based study of 15 698 cases from the surveillance, epidemiology and end results (SEER) program 1973-1991. Cancer 1997;79:564-73.
    • (1997) Cancer , vol.79 , pp. 564-573
    • Gilland, F.D.1    Hunt, W.C.2    Morris, D.M.3    Key, C.R.4
  • 2
    • 0031752682 scopus 로고    scopus 로고
    • Anaplastic thyroid carcinoma: Behavior, biology, therapeutic approach
    • Ain KB. Anaplastic thyroid carcinoma: behavior, biology, therapeutic approach. Thyroid 1998;8:715-26.
    • (1998) Thyroid , vol.8 , pp. 715-726
    • Ain, K.B.1
  • 3
    • 0037249255 scopus 로고    scopus 로고
    • Anaplastic thyroid cancer
    • Pasieka JL. Anaplastic thyroid cancer. Curr Opin Oncol 2003;15:78-83.
    • (2003) Curr Opin Oncol , vol.15 , pp. 78-83
    • Pasieka, J.L.1
  • 4
    • 0035039591 scopus 로고    scopus 로고
    • Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid
    • Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid. World J Surg 2001;25:617-22.
    • (2001) World J Surg , vol.25 , pp. 617-622
    • Sugitani, I.1    Kasai, N.2    Fujimoto, Y.3    Yanagisawa, A.4
  • 5
    • 0002049474 scopus 로고
    • Histological typing of thyroid tumors
    • Hedinger CE, editor Berlin: Springer-Verlag
    • Hedinger CE. Histological typing of thyroid tumors. In: Hedinger CE, editor. International histological classification of tumors. Vol 11. Berlin: Springer-Verlag; 1988. p. 22-3.
    • (1988) International Histological Classification of Tumors , vol.11 , pp. 22-23
    • Hedinger, C.E.1
  • 6
    • 0003809049 scopus 로고    scopus 로고
    • American Joint Committee on Cancer 6th ed. Thyroid. New York, NY: Springer Verlag
    • American Joint Committee on Cancer. Cancer Staging Manual. 6th ed. Thyroid. New York, NY: Springer Verlag; 2002. p. 77-87.
    • (2002) Cancer Staging Manual , pp. 77-87
  • 8
    • 0036121511 scopus 로고    scopus 로고
    • The important role of operations in the management of anaplastic thyroid carcinoma
    • Sugino K, Ito K, Mimura T, Nagahama M, Fukunari N, Kubo A et al. The important role of operations in the management of anaplastic thyroid carcinoma. Surgery 2002;131;245-8.
    • (2002) Surgery , vol.131 , pp. 245-248
    • Sugino, K.1    Ito, K.2    Mimura, T.3    Nagahama, M.4    Fukunari, N.5    Kubo, A.6
  • 9
    • 0035875896 scopus 로고    scopus 로고
    • Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival
    • Haigh PI, Ituarte PH, Wu HS, Treseler PA, Posner MD, Quivey JM et al. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer 2001;91:2335-42.
    • (2001) Cancer , vol.91 , pp. 2335-2342
    • Haigh, P.I.1    Ituarte, P.H.2    Wu, H.S.3    Treseler, P.A.4    Posner, M.D.5    Quivey, J.M.6
  • 11
    • 15744362272 scopus 로고    scopus 로고
    • Anaplastic thyroid carcinoma: Treatment outcome and prognostic factors
    • Kebebew E, Greenspan FS, Clark OH, Woeber KA, McMillan A et al. Anaplastic thyroid carcinoma: treatment outcome and prognostic factors. Cancer 2005;103:1330-5.
    • (2005) Cancer , vol.103 , pp. 1330-1335
    • Kebebew, E.1    Greenspan, F.S.2    Clark, O.H.3    Woeber, K.A.4    McMillan, A.5
  • 13
    • 35348890913 scopus 로고    scopus 로고
    • Ultrasound-guided percutaneous laser ablation treatment in inoperable aggressive course anaplastic thyroid carcinoma: The introduction of a novel alternative palliative therapy-second experience in literature
    • Cakir B, Topaloglu O, Gul K, Agac T, Aydin C, Dirikoc A et al. Ultrasound-guided percutaneous laser ablation treatment in inoperable aggressive course anaplastic thyroid carcinoma: the introduction of a novel alternative palliative therapy-second experience in literature. J Endocrinol Invest 2007;30:624-5.
    • (2007) J Endocrinol Invest , vol.30 , pp. 624-625
    • Cakir, B.1    Topaloglu, O.2    Gul, K.3    Agac, T.4    Aydin, C.5    Dirikoc, A.6
  • 14
    • 0036795865 scopus 로고    scopus 로고
    • Anaplastic thyroid carcinoma: Comparison of conventional radiotherapy and hyperfractionation chemoradiotherapy in two groups
    • Heron DE, Karimpour S, Grigsby PW. Anaplastic thyroid carcinoma: comparison of conventional radiotherapy and hyperfractionation chemoradiotherapy in two groups. Am J Clin Oncol 2002;25:442-6.
    • (2002) Am J Clin Oncol , vol.25 , pp. 442-446
    • Heron, D.E.1    Karimpour, S.2    Grigsby, P.W.3
  • 15
    • 0037125034 scopus 로고    scopus 로고
    • Anaplastic thyroid carcinoma: Three protocols combined doxorubicin, hyperfractionated radiotherapy and surgery
    • Tennvall J, Lundell G, Wahlberg P, Bergenfelz A, Grimelius L, Akerman M et al. Anaplastic thyroid carcinoma: three protocols combined doxorubicin, hyperfractionated radiotherapy and surgery. Br J Cancer 2002;86:1848-53.
    • (2002) Br J Cancer , vol.86 , pp. 1848-1853
    • Tennvall, J.1    Lundell, G.2    Wahlberg, P.3    Bergenfelz, A.4    Grimelius, L.5    Akerman, M.6
  • 16
    • 0034962347 scopus 로고    scopus 로고
    • Improvement in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland
    • Nutting CM, Convery DJ, Cosgrove VP, Rowbottom C, Vini L, Harmer C et al. Improvement in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland. Radiother Oncol 2001;60:173-80.
    • (2001) Radiother Oncol , vol.60 , pp. 173-180
    • Nutting, C.M.1    Convery, D.J.2    Cosgrove, V.P.3    Rowbottom, C.4    Vini, L.5    Harmer, C.6
  • 20
    • 0033840233 scopus 로고    scopus 로고
    • Treatment of anaplastic thyroid carcinoma with paclitaxel: Phase 2 trial using ninety-six-hour infusion
    • Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group
    • Ain KB, Egorin MJ, DeSimone PA. Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group. Thyroid 2000;10:587-94.
    • (2000) Thyroid , vol.10 , pp. 587-594
    • Ain, K.B.1    Egorin, M.J.2    Desimone, P.A.3
  • 21
    • 0033768918 scopus 로고    scopus 로고
    • Cytotoxic activity of 2′, 2′ difluorodeoxycytidine (Gemcitabine) in poorly differentiated thyroid carcinoma cells
    • Ringel MD, Greenberg M, Chen X, Hayre N, Suzuki K, Priebat D et al. Cytotoxic activity of 2′, 2′ difluorodeoxycytidine (Gemcitabine) in poorly differentiated thyroid carcinoma cells. Thyroid 2000;10:865-9.
    • (2000) Thyroid , vol.10 , pp. 865-869
    • Ringel, M.D.1    Greenberg, M.2    Chen, X.3    Hayre, N.4    Suzuki, K.5    Priebat, D.6
  • 22
    • 0034523426 scopus 로고    scopus 로고
    • Adenovirus mediated tumor suppressor p 53 gene therapy for anaplastic thyroid carcinoma in vitro and in vivo
    • Nagayama Y, Yokoi H, Takeda K, Hasegawa M, Nishihara E, Namba H et al. Adenovirus mediated tumor suppressor p 53 gene therapy for anaplastic thyroid carcinoma in vitro and in vivo. J Clin Endocrinol Metab 2000;85:4081-6.
    • (2000) J Clin Endocrinol Metab , vol.85 , pp. 4081-4086
    • Nagayama, Y.1    Yokoi, H.2    Takeda, K.3    Hasegawa, M.4    Nishihara, E.5    Namba, H.6
  • 23
    • 0037986203 scopus 로고    scopus 로고
    • The selective tyrosine kinase inhibitor, ST 1571, inhibits growth of anaplastic thyroid cancer cells
    • Podtcheko A, Ohtsuru A, Tsuda S, Namba H, Saenko V, Nakashima M et al. The selective tyrosine kinase inhibitor, ST 1571, inhibits growth of anaplastic thyroid cancer cells. J Clin Endocrinol Metab 2003;88:1889-96.
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 1889-1896
    • Podtcheko, A.1    Ohtsuru, A.2    Tsuda, S.3    Namba, H.4    Saenko, V.5    Nakashima, M.6
  • 24
    • 2542458413 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors restore radioiodide uptake and retention in poorly differentiated and anaplastic thyroid cancer cells by espression of the sodium/iodide symporter, thyroperoxidase and thyroglobulin
    • Furuya F, Shimura H, Suzuki H, Taki K, Ohta K, Haraguchi K et al. Histone deacetylase inhibitors restore radioiodide uptake and retention in poorly differentiated and anaplastic thyroid cancer cells by espression of the sodium/iodide symporter, thyroperoxidase and thyroglobulin. Endocrinol 2004;145:2865-75.
    • (2004) Endocrinol , vol.145 , pp. 2865-2875
    • Furuya, F.1    Shimura, H.2    Suzuki, H.3    Taki, K.4    Ohta, K.5    Haraguchi, K.6
  • 25
    • 33751505528 scopus 로고    scopus 로고
    • Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells
    • Catalano MG, Fortunati N, Pugliese M, Poli R, Bosco O, Mastrocola R et al. Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells. J Endocrinol 2006;191:465-72.
    • (2006) J Endocrinol , vol.191 , pp. 465-472
    • Catalano, M.G.1    Fortunati, N.2    Pugliese, M.3    Poli, R.4    Bosco, O.5    Mastrocola, R.6
  • 27
    • 0003594866 scopus 로고    scopus 로고
    • Guidelines for the management of thyroid cancer
    • British Thyroid Association, Royal College of Physicians Perros P, editor. 2nd ed. London: Royal College Physicians
    • British Thyroid Association, Royal College of Physicians. Guidelines for the management of thyroid cancer. In: Perros P, editor. 2nd ed. Report the Thyroid Cancer Guidelines Update Group. London: Royal College Physicians; 2007.
    • (2007) Report the Thyroid Cancer Guidelines Update Group


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.